John Cassidy
VC | United KingdomAbout John Cassidy
Founder & CEO of Cambridge Cancer Genomics (YC S17), PhD in Cancer Evolution from University of Cambrige, Forbes 30 under 30 2019 and investor (Angel Investor & Partner @kindred capital).
Who is in the team
- - Partner
Interested in...
- Customers are other businesses (B2B)
- Has one or more Female Founder(s)
- Is Commercialising Research (more..)
- One or more of founding team have PhDs
How much they invest
$1,000 to $2,500,000 at Seed and Series A stages.
What they invest in
- AI
- Biotechnology
- Digital Health
- Health Care
- Healthcare
- Life Sciences
Where they invest
They invest in startups based in Europe, Germany and United Kingdom.